✦ LIBER ✦

Department of Defense Prostate Cancer Clinical Trials Consortium: A New Instrument for Prostate Cancer Clinical Research

✍ Scribed by Michael J. Morris; Ethan M. Basch; George Wilding; Maha Hussain; Michael A. Carducci; Celestia Higano; Philip Kantoff; William K. Oh; Eric J. Small; Daniel George; Paul Mathew; Tomasz M. Beer; Susan F. Slovin; Charles Ryan; Christopher Logothetis; Howard I. Scher

Book ID: 119935422
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 155 KB
Volume: 7
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2009.n.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ixabepilone, mitoxantrone, and prednison

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Clinical trials of immunotherapy for adv

Clinical trials of immunotherapy for advanced prostate cancer

✍ Katsuyuki Kuratsukuri; Nobuyasu Nishisaka; Richard F Jones; Ching Y Wang; Gabrie 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Update of clinical and basic science res

Update of clinical and basic science research on prostate cancer from the department of defense center for prostate disease research (DOD-CPDR)

✍ Moul, J W 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

160 POSTER Phase I-II study of MDV3100 i

160 POSTER Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials Consortium

✍ H. Scher; T. Beer; C. Higano; C. Logothetis; J. Shelkey; D. Hung; M. Hirmand; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB